Greater New York City Area, TN United States
Sr Principal Investigator at EMD Serono Inc.,
Medical / Health Care / Pharmaceuticals
CURAGEN CORPORATION, New Haven, CT 2004 – present
Project Leader (Department of Preclinical Drug Development)
Accomplishments
• Identified and validated several protein and antibody therapeutic candidates.
• Identified two novel targets (Angioarrestin & Semaphorin) & advanced to preclinical decision
• Optimized conditions for cell-based in vitro screening
• Member of IND team for advancing Velafermin through clinical trials for oral mucositis.
• Developed bio-analytical methodology in support of Velafermin pharmacology.
• Established and managed external research collaborations.
• Designed and developed methods for cell-based screening of small molecule targets (HDACi).